Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1005 of 1,261
  1. US 7704527

    Modified release compositions of milnacipran

    Collegium Pharmaceutical, Inc. · Granted Apr 27, 2010 · Expires Apr 22, 2030

    granted
  2. US 7704542

    Vitamin/mineral compositions with DHA

    Xanodyne Pharmaceuticals, Inc. · Granted Apr 27, 2010 · Expires Apr 22, 2030

    granted
  3. US 7704701

    Diagnosis of prostate cancer with SPAS-1 cancer antigen

    The Regents of the University of California · Granted Apr 27, 2010 · Expires Apr 22, 2030

    granted
  4. CA 2739557

    PRODUIT PHARMACEUTIQUE POUR AUGMENTER LA DOSE DE VACCIN ANTI-ALLERGIQUE

    ALK ABELLO AS [DK] · Granted Apr 22, 2010 · Expires Apr 17, 2030

    granted
  5. US 7700609

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Apr 20, 2010 · Expires Apr 15, 2030

    granted
  6. US 7700738

    Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

    The Regents of the University of California · Granted Apr 20, 2010 · Expires Apr 15, 2030

    granted
  7. US 7700128

    Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester

    Takeda Pharmaceutical Company Limited · Granted Apr 20, 2010 · Expires Apr 15, 2030

    granted
  8. US 7700777

    Crystalline forms of a biphenyl compound

    Theravance, Inc. · Granted Apr 20, 2010 · Expires Apr 15, 2030

    granted
  9. US 7700127

    Method and compositions for preparing and delivering rumen protected lipids, other nutrients and medicaments

    The Regents of the University of California · Granted Apr 20, 2010 · Expires Apr 15, 2030

    granted
  10. US 7700274

    Compositions and methods in cancer associated with altered expression of KCNJ9

    Sagres Discovery, Inc. · Granted Apr 20, 2010 · Expires Apr 15, 2030

    granted
  11. US 7700134

    Prevention of cisplatin induced deafness

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 20, 2010 · Expires Apr 15, 2030

    granted
  12. US 7700273

    Peptidomimetics that mimic a conformational-dependent neutralizing epitope of the human immunodeficiency virus (HIV) CCR5 coreceptor

    The United States of America, as represented by the Department of Health and Human Services · Granted Apr 20, 2010 · Expires Apr 15, 2030

    granted
  13. US 7700361

    Secretory or membrane protein expressed in skeletal muscles

    Takeda Pharmaceutical Company Limited · Granted Apr 20, 2010 · Expires Apr 15, 2030

    granted
  14. US 7700547

    Preventing airway mucus production by administration of EGF-R antagonists

    The Regents of the University of California · Granted Apr 20, 2010 · Expires Apr 15, 2030

    granted
  15. US 7700600

    Methods for treating cardiac arrhythmia

    The United States of America · Granted Apr 20, 2010 · Expires Apr 15, 2030

    granted
  16. US 7700578

    Capsule composition for use as immunogen against Campylobacter jejuni

    United States of America as represented by the Secretary of the Air Force · Granted Apr 20, 2010 · Expires Apr 15, 2030

    granted
  17. US 7700641

    Spiro-oxindole compounds and their uses as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Apr 20, 2010 · Expires Apr 15, 2030

    granted
  18. US 7700651

    Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease

    The Board of Regents of the University of Texas System · Granted Apr 20, 2010 · Expires Apr 15, 2030

    granted
  19. US 7700550

    Glycopeptide phosphonate derivatives

    Theravance, Inc. · Granted Apr 20, 2010 · Expires Apr 15, 2030

    granted
  20. US 7700655

    Antiallergic agents

    Institute of Medicinal Molecular Design, Inc. · Granted Apr 20, 2010 · Expires Apr 15, 2030

    granted
  21. US 7695737

    Spherical composite particles and cosmetics with the particles blended therein

    JGC Catalysts and Chemicals Ltd. · Granted Apr 13, 2010 · Expires Apr 8, 2030

    granted
  22. US 7696227

    Small-molecule inhibitors of the androgen receptor

    The Regents of the University of California · Granted Apr 13, 2010 · Expires Apr 8, 2030

    granted
  23. US 7696218

    Substituted 1,3-dialkyl-2,4-dioxo-6-(arylamino)-1,2,3,4-tetrahydropyrimidine-5-hydroxamic acid inhibitors of MAPK/ERK kinase

    Takeda San Diego, Inc. · Granted Apr 13, 2010 · Expires Apr 8, 2030

    granted
  24. US 7696159

    Treatment for basal cell carcinoma

    Graceway Pharmaceuticals. LLC · Granted Apr 13, 2010 · Expires Apr 8, 2030

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.